The Latest Cardiac and Vascular News
DALLAS–(BUSINESS WIRE)–NeuWire Medical today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for STROKE-REWIRE, a pivotal study evaluating the ReWire Vagus Nerve Stimulation System in patients with chronic ischemic stroke and upper-limb dysfunction. The prospective, multicenter, randomized, sham-controlled study will enroll up to 135 participants across up to 12 U.S. clinical sites. Study initiation is expected in t
DALLAS–(BUSINESS WIRE)–NeuWire Medical, a medical device company advancing the development of a targeted plasticity therapy platform for individuals living with chronic ischemic stroke, today announced the appointment of Ramin Mousavi as Executive Chairman of the Board. His arrival marks an important step in the company’s next phase of growth as NeuWire Medical prepares to advance its clinical, regulatory, and financing strategy. Ramin joins NeuWire Medical following his role as President, Ch
